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Table 1
Positive and negative ion lipid molecular species identiﬁed by MS/MS
m/z peak Lipid assignment Designation
184.0 Phosphocholine [M+H]+
725.5 SM (d18:1/16:0) [M+Na]+
729.5* SM (d18:1/18:1) [M+H]+
739.5 PC (16:0/18:1-N(CH3)3) [M+K]+
741.5 SM (d18:1/16:0) [M+K]+
750.5* PE (18:0/20:4) [M-H]-
756.5* PC (16:0/16:0) [M+Na]+
767.5 SM (d18:1/19:0) or SM(d18:1/18:1) [M+Na]+ or [M+K]+
790.5* PC (18:0/18:0) [M+H]+
798.5 PC (16:0/18:1) [M+K]+
826.6 PC (18:0/18:1) [M+K]+
853.6 SM (d18:1/24:0) [M+K]+
885.6* PI (C18:0/C20:4) [M-H]-
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S49Methods: Human normal/OA cartilage and normal/OA synovial mem-
branes were sectioned in triplicate in 10 mm thick sections and sub-
sequently washed and digested. Microspots of trypsin were deposited by
means of an automatic chemical inkjet printer with high positional
accuracy. Alpha-Cyano-4-hydroxycinnamic acid matrix (HCCA) was
deposited by a vibrational sprayer system. A Synapt HDMSMALDI-Q-TOF
instrumentwasused to perform the imaging-MSandMS/MSexperiments
with a spatial raster size of 150 mm. Principal Component Analysis (PCA)
and discriminant analysis (DA) were used to build regional molecualr
classiﬁers. A Mascot query was performed after MS/MS experiments for
protein identiﬁcation. The location of tryptic peptideswas visualizedwith
Biomap. Hematoxylin-eosin staining and immunohistochemistry studies
validated and complemented the spatial information.
Results: We have studied the peptide distribution in normal and OA
human synovial tissues by MALDI-MSI. By means of PCA and DA we
distinguished OA and normal tissues based on their tryptic peptide
proﬁles. Tryptic peptides from proteins such as hemoglobin subunit
alpha 2 (m/z 1529.8), hemoglobin subunit beta (m/z 952.5, m/z 1126.6,
m/z 1274.7, m/z 1314.7, m/z 1720.0), actin aortic smooth muscle (m/z
1790.9), biglycan (m/z 1312.8) and ﬁbronectin (m/z 1349.7) have been
identiﬁed, for the ﬁrst time to our knowledge, directly from synovial
membrane biopsies. We have determined the localization of OA related
markers such as the heme group, hemoglobin and ﬁbronectin, all of
them co-localized to inﬂamed areas. Biomap software revealed that the
average intensity for group hemewas higher in OA compared to normal
synovial membrane (0,0110,003 vs. 0,0910,029; p<0.05). Fibro-
nectin immunohistochemistry provided complementary validation of
the results obtained by MALDI-MSI. On the other hand, phosphocoline
(m/z 184) was assigned as a marker of OA tissues but localized in areas
of low inﬂammation. Cluster analyses revealed that peaks assigned to
diacylglycerols and actin were molecular signatures speciﬁc to normal
tissues. Finally, we studied common OA peptides analyzing human
synovial and cartilage tissue sections. We have observed that ﬁbro-
nectin and actin related peptides clearly distinguished the diseased
from the normal tissues. Pathway analyses revealed that ﬁbronectin,
hemoglobin and other OA related proteins interacted with integrin
proteins suggesting that this family of proteins has an important role in
the process of cartilage degradation and synovial inﬂammation.
Conclusions: We have classiﬁed normal and OA human synovial
membranes byMALDI-MSI. Peptides exclusively located in areas of high
inﬂammation were identiﬁed revealing disease speciﬁc proﬁles that
contribute to the understanding of OA affected tissues at the molecular
level.
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Purpose: Recent investigations have argued that there is a close rela-
tionship between altered lipid metabolism and Osteoarthritis (OA)
disease. Mesenchymal stem cells (MSC) are an interesting alternative
for cell-based therapy of cartilage defects due to their capacity to dif-
ferentiate towards chondrocytes in a process called chondrogenesis.
The knowledge of the lipid distribution and modulation during this
process could be used to improve the MSC-based cartilage therapy by
the discovery of new chondrogenic markers. In this study, we have used
matrix-assisted laser desorption/ionization mass spectrometry imaging
(MALDI-MSI) for the characterization of lipids in 3D MSC cultures
(micromasses) at different time points of chondrogenesis.
Methods: MSC micromasses obtained from the bone marrow of 3 OA
donors were collected at day 2 and 14 of chondrogenesis and studied in
duplicate. Samples were cut in sections of 10 mm thickness and dried in
a vacuum desiccator for 20 min to prevent the molecular delocalization.
Two matrix solutions were prepared (Alpha-cyano-4-hydroxycinnamic
acid at 10 mg/ml in 70:30 methanol:triﬂuoroacetic acid 0.2%; 9-Ami-
noacridine at 10 mg/ml in 70:30 ethanol:water) and applied on the
surface of the tissue slides using a vibrational sprayer (ImagePrep,
Bruker, Germany). MALDI-MSI was performed using a MALDI-Q-TOF
instrument (Synapt HDMS, Waters, UK) equipped with a 200-HzNd:YAG laser. Data were acquired in the mass/charge (m/z) range of
100-1000 and at a raster size of 100 mm (positive and negative V-
reﬂectron mode). Ion images were generated with Biomap 3.7.5.5
software. Principal component analysis (PCA) and discriminant analysis
(DA) were used to look for the masses with the highest differences
between all samples studied. Finally, tandem mass spectrometry (MS/
MS) was carried out to identify these masses. Lipid assignments were
performed according to literature and LIPID MAPS Structure Database
(LMSD).
Results: MALDI-MSI revealed a differential lipid proﬁle between the
two time points (2 and 14 days). Firstly, we analyzed the lipid compo-
sition in the positive mode. The analysis of 683 spectra by statistical
methods such as PCA and DA showed a higher lipid content at day 2 of
chondrogenesis. According to Lipidmaps database and MS/MS frag-
mentation, these peaks are attributed to phosphocholine (m/z 184) and
several phosphatidylcholines (PC) (m/z 739.5, m/z 798.5 andm/z 826.6)
(Table 1). Other differentially expressed peaks could be assigned to
sphingomyelines (SM) (m/z 725.5, m/z 741.5, m/z 767.5 and m/z 826.6).
Only m/z 729.5, m/z 756.5 and m/z 790.5 were increased at day 14,
corresponding to SM and two PCs, respectively. For the negative mode
745 spectra were used. The ﬁrst discriminant function revealed a high
presence of phosphatidylinositols (PI) (m/z 885.6) and phosphatidyle-
tanolamines (PE) such as m/z 750.5 speciﬁcally at day 14. Biomap
software conﬁrmed the results obtained by PCA and DA (Figure 1).
Conclusions: These data demonstrate that MALDI-MSI can be used for
the identiﬁcation of putative chondrogenic markers. We have observed
that the lipid metabolism is involved in the chondrogenic process.
Phosphatidyletanolamine and phosphatidylinositol pathways are
increased in chondrocyte-differentiated MSC, whereas phosphocho-
line-related lipids could be markers of the undifferentiated stage.75
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